Skip to content

Weiss Multi-Strategy Advisers LLC

Follow

13F filer, CIK 1388312, NEW YORK, NY

Weiss Multi-Strategy Advisers LLC reported $0 across 1 holding for the quarter ended 2024-03-31, in a 13F-HR filed 2024-04-12.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001062574-24-000004

Period
2024-03-31
Reported value
$0
Holdings
1
Top 10 weight
New
1
Sold out
524

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SBACexited-515,100-$131M
REXRexited-2,244,720-$126M
COLDexited-3,787,437-$115M
BXPexited-1,623,747-$114M
CUZexited-3,323,897-$80.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Back to all 1 share positions

Sold out in Q1 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
TMCITREACE MED CONCEPTS INC20,000$255Kshares
AKOYA BIOSCIENCES INC COMAKOYA BIOSCIENCES INC COM50,997$249Kshares
DXCMDEXCOM INC2,000$248Kput
PASSAGE BIO INCPASSAGE BIO INC242,900$245Kshares
NEXTNEXTDECADE CORP51,247$244Kshares
DISDISNEY WALT CO2,630$237Kshares
XENEXENON PHARMACEUTICALS INC5,000$230Kshares
ASTLALGOMA STL GROUP INC20,000$201Kcall
EOSEEOS ENERGY ENTERPRISES INC172,938$189Kshares
FREYR BATTERYFREYR BATTERY100,000$187Kcall
FREYR BATTERYFREYR BATTERY87,964$164Kshares
HNRGHALLADOR ENERGY COMPANY17,452$154Kshares
HRTXHERON THERAPEUTICS INC90,000$153Kshares
PNTGPENNANT GROUP INC10,707$149Kshares
RIGEL PHARMACEUTICALS INCRIGEL PHARMACEUTICALS INC101,278$147Kshares
FLLFULL HSE RESORTS INC24,476$131Kshares
PTONPELOTON INTERACTIVE INC21,248$129Kshares
TTITETRA TECHNOLOGIES INC DEL26,017$118Kshares
OISOIL STS INTL INC16,649$113Kshares
BORRBORR DRILLING LTD10,770$79Kshares
KOSKOSMOS ENERGY LTD11,542$77Kshares
AMBPARDAGH METAL PACKAGING S A15,000$58Kshares
PRECISION BIOSCIENCES INCPRECISION BIOSCIENCES INC107,386$39Kshares
KARYOPHARM THERAPEUTICS INCKARYOPHARM THERAPEUTICS INC27,043$23Kshares

How Q1 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001062574-24-000004 base2024-04-12acceptance time not in the bulk data set